Atopic Dermatitis: A Deep Dive into Positive Progress of the Frontier, a Novel Topical Phage-based Treatment for Atopic Dermatitis

Time: 11:00 am
day: Day One

Details:

  • Rationale for BX005, phage treatment targeting S. Aureus
  • BX005 characteristics and pre-clinical results
  • BX005 clinical study

Speakers: